Topamax For Depression
Effectiveness of treatment was analyzed by contrasting each Topamax ® treatment group to inactive medicine (ITT population) for the percent decrease from baseline to the last 12 weeks of the double-blind phase in the monthly migraine attack rate (key endpoint).
This suggests that breastfeeding or expectant females should first speak with their healthcare company and weight up all the dangers and benefits linked with the treatment - and just then begin taking this medicine.